Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FibroGen
Biotech
Cue Biopharma queues up J&J vet as CBO—Chutes & Ladders
Cue Biopharma queues up J&J vet as CBO. Transgene taps two new oncology leaders. Cassava looks to steady ship with new CEO.
Darren Incorvaia
,
Zoey Becker
Sep 13, 2024 8:30am
FibroGen lays off 75% of US staff as asset flunks 2 more trials
Jul 31, 2024 7:22am
Prostate cancer ADC breaks FibroGen's clinical losing streak
Apr 3, 2024 10:55am
Another Biogen exec hitches ride to Voyager —Chutes & Ladders
Mar 15, 2024 9:30am
FibroGen fails in DMD, continuing rotten run of phase 3 flops
Aug 30, 2023 5:54am
Pfizer exec out the door—Chutes & Ladders
Jul 28, 2023 9:30am